Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.
暂无分享,去创建一个
W. Rogers | G. Knatterud | E. Passamani | J. Willerson | C. Lambrew | R. Roberts | S. Forman | Hugh C. Smith | H. Smith | H. Mueller | D. Diver
[1] J. Gore,et al. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. , 1990, Circulation.
[2] E. Braunwald,et al. Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial. , 1989, Journal of the American College of Cardiology.
[3] R. Steingart,et al. Effects of intravenous metoprolol on global and regional left ventricular function after coronary arterial reperfusion in acute myocardial infarction. , 1989, The American journal of cardiology.
[4] Lilleyman Js,et al. Working Paper 6 on the National Health Service. , 1989 .
[5] S. Willich,et al. Suppression of silent ischemia by metoprolol without alteration of morning increase of platelet aggregability in patients with stable coronary artery disease. , 1989, Circulation.
[6] Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. , 1989, The New England journal of medicine.
[7] F. Van de Werf,et al. Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction. , 1988, BMJ.
[8] A. M. Skene,et al. TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION Anglo-Scandinavian Study of Early Thrombolysis (ASSET) , 1988, The Lancet.
[9] L. Bolognese,et al. RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2 , 1988, The Lancet.
[10] F. Sheehan,et al. Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: an important determinant of survival. , 1988, Journal of the American College of Cardiology.
[11] ISIS-1 Collaborative Group. MECHANISMS FOR THE EARLY MORTALITY REDUCTION PRODUCED BY BETA-BLOCKADE STARTED EARLY IN ACUTE MYOCARDIAL INFARCTION: ISIS-1 , 1988, The Lancet.
[12] Aims Trial Study Group. EFFECT OF INTRAVENOUS APSAC ON MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION: PRELIMINARY REPORT OF A PLACEBO-CONTROLLED CLINICAL TRIAL , 1988, The Lancet.
[13] H. Lambertz,et al. THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY , 1988, The Lancet.
[14] E. Braunwald,et al. Update from the Thrombolysis in Myocardial Infarction Trial. , 1987, Journal of the American College of Cardiology.
[15] K. Lee,et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. , 1987, The New England journal of medicine.
[16] K. C. Srivastava. Influence of some beta blockers (pindolol, atenolol, timolol and metoprolol) on aggregation and arachidonic acid metabolism in human platelets. , 1987, Prostaglandins, leukotrienes, and medicine.
[17] A. Ross,et al. Reinfarction, recurrent angina, and reocclusion after thrombolytic therapy. , 1987, Circulation.
[18] S. Yusuf. Interventions that potentially limit myocardial infarct size: overview of clinical trials. , 1987, The American journal of cardiology.
[19] F. Van de Werf,et al. Reduction in infarct size and enhanced recovery of systolic function after coronary thrombolysis with tissue-type plasminogen activator combined with beta-adrenergic blockade with metoprolol. , 1987, Circulation.
[20] A. Ichikawa,et al. Beta 2-adrenergic regulation of prostaglandin D2 receptor in rabbit platelets. , 1987, Biochimica et biophysica acta.
[21] K. Winther. The Effect of &bgr;‐Blockade on Platelet Function and Fibrinolytic Activity , 1987, Journal of cardiovascular pharmacology.
[22] P. Serruys,et al. Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. , 1986, Journal of the American College of Cardiology.
[23] K. Swedberg,et al. ADP-induced platelet aggregation and metoprolol treatment of myocardial infarction patients. A controlled study. , 2009, Acta medica Scandinavica.
[24] W. Ganz,et al. The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.
[25] C. Forbes,et al. A Comparative Study of the Effects of Adrenoceptor Antagonists on Platelet Aggregation and Thromboxane Generation , 1985, Thrombosis and Haemostasis.
[26] J. Willerson,et al. Effects of propranolol and diltiazem alone and in combination on the recovery of left ventricular segmental function after temporary coronary occlusion and long-term reperfusion in conscious dogs. , 1985, Circulation.
[27] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[28] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.
[29] A. Jaffe,et al. Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial. , 1984, The New England journal of medicine.
[30] E. Braunwald,et al. Enhancement of salvage of reperfused myocardium by early beta-adrenergic blockade (timolol). , 1984, Journal of the American College of Cardiology.
[31] P. Lundborg,et al. The peripheral platelet count and ADP-induced platelet aggregation in response to metoprolol and propranolol as studied in young healthy male volunteers. , 2009, Scandinavian journal of haematology.
[32] F. Sheehan,et al. Effect of interventions in salvaging left ventricular function in acute myocardial infarction: a study of intracoronary streptokinase. , 1983, The American journal of cardiology.
[33] E. Braunwald,et al. First ultra-short-acting beta-adrenergic blocking agent: its effect on size and segmental wall dynamics of reperfused myocardial infarcts in dogs. , 1983, The American journal of cardiology.
[34] A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. , 1982, JAMA.
[35] K. Swedberg,et al. EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION A Double-blind Randomised Trial , 1981, The Lancet.
[36] Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. , 1981, The New England journal of medicine.
[37] J. Sebus,et al. THE SIMIAN CREASE. , 1964, Lancet.
[38] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .